N
Natixis Portfolio holdings
AUM
$20.1B
1-Year Return
17.51%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Quarter Return
+26.28%
1 Year Return
+17.51%
3 Year Return
+106.1%
5 Year Return
+162.29%
10 Year Return
+380.38%
AUM
$12.9B
AUM Growth
+$151M
(+1.2%)
Cap. Flow
-$2.51B
Cap. Flow
% of AUM
-19.52%
Top 10 Holdings %
Top 10 Hldgs %
34.42%
Holding
917
New
232
Increased
199
Reduced
245
Closed
202
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$363M |
| 2 |
Vale
VALE
|
+$189M |
| 3 |
S&P Global
SPGI
|
+$144M |
| 4 |
AT&T
T
|
+$137M |
| 5 |
SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$129M |
Top Sells
| 1 |
Apple
AAPL
|
+$490M |
| 2 |
Microsoft
MSFT
|
+$455M |
| 3 |
Merck
MRK
|
+$176M |
| 4 |
Starbucks
SBUX
|
+$162M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$155M |
Sector Composition
| 1 | Consumer Discretionary | 13.33% |
| 2 | Technology | 11.79% |
| 3 | Healthcare | 9.81% |
| 4 | Financials | 9.42% |
| 5 | Industrials | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Quince Therapeutics
QNCX
$84.3M
| $564K | ﹤0.01% |
12,181
-4,414
| -27% | -$204K |
|
602
Cintas
CTAS
$81.7B
| $560K | ﹤0.01% |
8,412
-646,264
| -99% | -$43M |
|
603
Cadence Design Systems
CDNS
$98.3B
| $555K | ﹤0.01% |
5,781
-66,301
| -92% | -$6.37M |
|
604
Nutrien
NTR
$27.9B
| $553K | ﹤0.01% |
17,267
+9,368
| +119% | +$300K |
|
605
Clorox
CLX
$15.4B
| $552K | ﹤0.01% |
2,518
-395,751
| -99% | -$86.8M |
|
606
Shake Shack
SHAK
$3.93B
| $547K | ﹤0.01% |
10,330
| – | – |
|
|
IBTX
607
DELISTED
Independent Bank Group, Inc.
IBTX
| $543K | ﹤0.01% |
+13,396
| New | +$543K |
|
608
TC Energy
TRP
$53.9B
| $542K | ﹤0.01% |
+12,728
| New | +$542K |
|
609
WisdomTree Japan Hedged Equity Fund
DXJ
$3.81B
| $539K | ﹤0.01% |
11,455
-6,427
| -36% | -$302K |
|
610
Bank of Montreal
BMO
$90.9B
| $537K | ﹤0.01% |
10,111
-20,652
| -67% | -$1.1M |
|
611
Universal Health Services
UHS
$11.8B
| $524K | ﹤0.01% |
5,637
-23,294
| -81% | -$2.17M |
|
612
Zillow
ZG
$21B
| $517K | ﹤0.01% |
+9,000
| New | +$517K |
|
613
Pultegroup
PHM
$27.9B
| $516K | ﹤0.01% |
15,176
-72,764
| -83% | -$2.47M |
|
614
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.13B
| $511K | ﹤0.01% |
14,764
| – | – |
|
615
JD.com
JD
$46.6B
| $503K | ﹤0.01% |
8,437
-69,388
| -89% | -$4.14M |
|
616
KeyCorp
KEY
$21B
| $502K | ﹤0.01% |
+41,211
| New | +$502K |
|
617
Q2 Holdings
QTWO
$5.25B
| $498K | ﹤0.01% |
+5,800
| New | +$498K |
|
618
Compañía de Minas Buenaventura
BVN
$5.08B
| $496K | ﹤0.01% |
54,293
+1
| +0% | +$9 |
|
619
Healthpeak Properties
DOC
$12.7B
| $492K | ﹤0.01% |
17,858
-14,035
| -44% | -$387K |
|
620
Schneider National
SNDR
$4.29B
| $488K | ﹤0.01% |
+19,800
| New | +$488K |
|
|
B
621
Barrick Mining Corporation
B
$49.5B
| $485K | ﹤0.01% |
18,007
-11,954
| -40% | -$322K |
|
622
Ionis Pharmaceuticals
IONS
$9.72B
| $484K | ﹤0.01% |
+8,210
| New | +$484K |
|
623
GSK
GSK
$80.6B
| $481K | ﹤0.01% |
+9,432
| New | +$481K |
|
624
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.5B
| $468K | ﹤0.01% |
4,285
-282
| -6% | -$30.8K |
|
625
Invesco S&P 500 Pure Growth ETF
RPG
$1.73B
| $467K | ﹤0.01% |
18,045
| – | – |
|